POSTSTROKE DEPRESSION
- Авторлар: Domashenko M.A.1, Maksimova M.Y.1, Orlov S.V.1, Shchukina E.P.1, Domashenko MA1, Maksimova MY.1, Orlov SV1, Shcukina EP1, Goncharova EM1
-
Мекемелер:
- Шығарылым: № 19 (2011)
- Беттер: 15-19
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/279112
- ID: 279112
Дәйексөз келтіру
Толық мәтін
Аннотация
Негізгі сөздер
Авторлар туралы
Maksim Domashenko
Marina Maksimova
Sergey Orlov
Elena Shchukina
M Domashenko
M Maksimova
S Orlov
E Shcukina
E Goncharova
Әдебиет тізімі
- Гехт А.Б., Боголепова А.Н., Сорокина И.Б. Депрессия после инсульта: опыт применения ципрамила // Журнал неврологии и психиатрии 2002. Т. 102. № 5. С. 36-40.
- Гехт А.Б., Сорокина И.Б., Боголепова А.Н. и соавт. Опыт применения иксела (милнаципрана гидрохлорида) в лечении постинсультной депрессии // Терапевтический архив 2003. Т. 75. № 10. С. 34-8.
- Гусев Е.И., Гехт А.Б. Реабилитация в неврологии. Учебное пособие. М., 2000.
- Гусев Е.И., Гехт А.Б., Боголепова А.Н., Сорокина И.Б. Особенности депрессивного синдрома у больных, перенесших ишемический инсульт // Журнал неврологии и психиатрии, приложение "Инсульт" 2001. №. 3. С. 28-31.
- Смулевич А. Б. Депрессии в общемедицинской практике. М., 2000.
- Сорокина И.Б. Депрессия у больных ишемическим инсультом. Дисс. канд. мед. наук. М., 2005.
- Andersen G, et al. Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994;25(6):1099-104.
- Berg A, et al. Poststroke depression in acute phase after stroke. Cerebrovasc Dis 2001;12(1):14-20.
- Bhogal SK, et al. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression. J Am Geriatr Soc 2005;53:1051-57.
- Black KG. Diagnosing depression after stroke. South Med J 1995;88(7):699-708.
- Charles E. Mortality and Poststroke Depression Am J Psychiatry 2004;161:1506.
- Choi-Kwon S, et al. Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a doubleblind, placebo-controlled study. Stroke 2006;37(1):156-61.
- Colonna L, et al. Escitalopram is well tolerated and more efficacious than citalopram in long-term treatment of moderately depressed patients. Poster presented at the 3rd International Forum on mood and anxiety disorders, Monte Carlo, Monaco 2002;27-30.
- Diequez S, et al. Is poststroke depression a vascular depression? J Neurol Sci 2004;226(1-2):53-8.
- Duman RS, et al. Arch Gen Psyhiatry 199;54:597.
- Erfurth A, et al. Depressive disorders in neurologic rehabilitation: therapy with paroxetine. Psychiatr Prax 2001;28(1):43-4.
- Feys HM, et al. Stroke 1998;29:785.
- Hackett ML, et al. Management of depression after stroke: A systematic review of pharmacological therapies. Stroke 2005;36:1098-103.
- Hackett ML, Anderson CS. Predictors of depression after stroke: A systematic review of observational studies. Stroke 2005;36:2296-301.
- Hallet M. Brain Res Rev 2001;36:169.
- Huff W, et al. Poststroke depression: diagnosis and therapy. Fortschr Neurol Psychiatr 2001; 69(12):581-91.
- Gresham GE, et al. Stroke 1997;28:1522.
- Gonzalez-Torrecillas JL, et al. Effects of early treatment of poststroke depression on neuropsychological rehabilitation. Int Psychogeriatr 1995;7(4):547-60.
- Iacoboni M, et al. Poststroke depression: relationships with morphological damage and cognitive over time. Int J Neurol Sci 1995;16:209-15.
- Kauhanen M, et al. Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 1999;30(9):1875-80.
- Kim JS, Choi-Kwon S. Poststroke depression and emotional incontinence: correlation with lesion location. Neurology 2000;54(9):1805-10.
- Kwakkel G, et al. Neurol Neurosurg Psyhiatr 2002;72:473.
- Lepola UM, et. al. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Int Clin Psychopharrnacol 2003;18:211-17.
- Linden T, et al. Depressive disorders after 20 months in elderly stroke patients: A case-control study. Stroke 2007;38:1860-63.
- Mayo NE, et al. Activity, participation, and quality of life 6 months poststroke. Arch Phys Med Rehabil 2002;83(8):1035-42.
- Narushima K, et al. Preventing poststroke depression: a 12-week double-blind randomized treatment trial and 21-month follow-up. J Nerv Ment Dis 2002;190(5):296-303.
- Paolucci S, et al. Stroke 2003;34:2861.
- Paolucci S, et al. Functional outcome in stroke inpatient rehabilitation: Predicting no, low and high response patients. Cerebrovasc Dis 1998;8:228-34.
- Paradiso S, Robinson RG. Gender differences in poststroke depression. J Neuropsychiatry Clin Neurosci 1998; 10(1):41-7.
- Pohjasvaara T, et al. Frequency and clinical determinants of poststroke depression. Stroke 1998; 29(11):2311-17.
- Ramasubbu R, et al. Functional impairment associated with acute poststroke depression: the Stroke Data Bank Study. J Neuropsychiatry Clin Neurosci 1998;10(1):26-33.
- Robinson RG, et al. Depression and cerebrovascular disease. J Clin Psychiatry 1990;51:26-31; discussion 32-3.
- Robinson RG, et al. Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial. JAMA 2008;299(20):2391-400.
- Sanchez C, Kreilgaard M. R-citalopram ingibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram. Pharmacol Biochem Behav 2004;77:391-98.
- Sato P, et al. Neuroanatomic and functional correlates of depressed mood: the Cardiovascular Health Study. Am J Epidemiol 1999;150:919-29.
- Sandor H, et al. Clinical evaluation of the efficacy and safety of paroxetin in poststroke depression: results from a phase 4, open label, multicentre clinical trial with 26 weeks of follow-up. Orv Hetil 2006;147(50):2397-404.
- Schwartz JA, et al. Depression in stroke rehabilitation. Biol Psychiatry 1993;33(10):694-9.
- Shima S, et al. Poststroke depression: Gen Hosp Psychiatry 1994;16(4): 286-9.
- Shimoda K, Robinson RG. The relationship between poststroke depression and lesion location in long-term follow-up. Biol Psychiatry 1999;45(2):187-92.
- Tange A, et al. Acta Psychiatr Scand 1997;96:134.
- Thomas SA, Lincoln NB. Factors relating to depression after stroke. Br J Clin Psychol 2006;45:49-61.
- van de Meent H, et al. Pharmacologic treatment of poststroke depression: A systematic review of the literature. Top Stroke Rehabil 2003;10:79-92.
- Varga D. Neuropsychiatric complications after stroke. Ideggyogy Sz 2002;55(3-4):128-36.
- Verdelho A, Henon H. Depressive symptoms after stroke and relationship with dementia: a three-year follow-up study. Neurology 2004;62(6):905-11.
- Wiart L, et al. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study. Stroke 2000;31(8):1829-32.
- Williams LS, Ghose SS, Swinde R.W. Depression and other mental health diaognoses increase mortality riskafter ischemic stroke. Am J Psychiatry 2004;161(6):1090-5.
- Whyte E, Mulsant B. Poststroke depression: epidemiology, pathophysiology, and biological treatment. Biol Psychiatry 2002;52(3):253.
- Yamakawa Y, et al. Efficacy of milnacipran on poststroke depression on inpatient rehabilitation. Psychiatry Clin Neurosci 2005;59(6):705-10.
- Zigmond AS, Snaith PP. Acta Psychiatr Scand 1983;67:361.